SAEVA Proceedings 2014 | Page 108

46TH  ANNUAL  CONGRESS  OF  THE  SAEVA        SKUKUZA      16-­‐20  FEBRUARY  2014 108       • • • Considered baseline drug class for standing sedation, but needs to be combined with other agents to: (1) lower the required dose, (2) improve analgesia and (3) minimise the negative effects the combined drugs. Tip when using this class of drug: Wait for maximum onset of action before disturbing the horse! Adrenaline and increased sympathetic tone will decrease the efficacy of sedation in horses. Thus, make sure your timing is appropriate. All drugs in this class should, ideally, be bolused followed by a constant rate infusion (for long procedures). If the initial bolus does not provide the required level of sedation, then consider administering a follow-up bolus to achieve the desired level of sedation. Achieving the desired level of sedation before commencing a procedure will ensure a more stable sedation without the seesaw phenomenon. Opioids: • • • • • • • • Do not cause any sedation in horses, may not even decrease the amount of α2-adrenoreceptor agonists required. Provide excellent analgesia for dull throbbing pains. Considered essential to include in all surgical procedures. Butorphanol (Ringer et al. 2012a, Ringer et al. 2012b, Latimer et al. 2002, Clarke et al. 1991, Wilson et al. 2002), morphine and buprenorphine (Taylor et al. 2013) have been used in combination with α2-adrenoreceptor agonists with great success. May cause increased respiratory depression in combination with α2adrenoreceptor agonists. Oxygen insufflation via nasal intubation is usually adequate to overcome the hypoventilation. Best to bolus initial dose followed by a constant rate infusion. Overdose may cause increased locomotor behavioural disorders (Tranquilli et al. 2007, Hall et al. 2001). Morphine has been administered via the epidural route to provide prolonged analgesia. Local anaesthetics: • •   Lidocaine has been used as a visceral analgesic (laparoscopy) and as a prokinetic to buffer the effects of the α2-adrenoreceptor agonists and opioids on gastrointestinal motility. It may play an effective role in prolonged standing sedation. Bolusing or bolus followed by a constant rate infusion may be used. Boluses doses (0.5 to 1 mg/kg) and infusion rates (0.5 to 1 mg/kg/hr) have not been studied in combination with constant rate infusion used for standing sedation. However, they have been used in various clinical cases with success. The effect may be anecdotal within this context. 108